Groove Botanicals Inc. is an early-stage company transitioning its focus to identifying and evaluating early-stage intellectual property and applied technologies from Norwegian universities and research institutions for potential licensing and commercialization in North America. The company has no current products, technologies, or intellectual property rights and is in the process of establishing its new business model. Operating expenses for the fiscal year ended March 31, 2026, were $139,917, an increase from $130,834 in the prior year, primarily due to higher consulting expenses. The company reported a net loss of $139,917 for the fiscal year ended March 31, 2026, compared to a net loss of $130,834 for the prior year. Significant preferred stock dividends, totaling $218,470 for both fiscal years, contributed to the net loss attributable to common shareholders. The company has a substantial accumulated deficit of $35,554,968 as of March 31, 2026, raising substantial doubt about its ability to continue as a going concern. The company's auditor has expressed substantial doubt about its ability to continue as a going concern. There are material weaknesses in internal control over financial reporting due to inadequate segregation of duties and lack of an audit committee with a financial expert. The company's CEO, Kent Rodriguez, holds significant voting power (51%) through Series A Preferred Stock and is the primary source of related party financing. The company is seeking additional capital through equity or debt financing to fund its operations and business objectives.